Digostics and AgaMatrix partner to provide home OGTT testing for UK expectant mothers through NHS, increasing gestational diabetes screening.

Digostics and AgaMatrix partner to introduce Oral Glucose Tolerance (OGTT) home testing for UK expectant mothers, accelerating gestational diabetes screening within the UK National Health Service. Digostics' GTT@home service, the world's first home-use OGTT, is approved for distribution to the NHS through AgaMatrix on an exclusive basis. This partnership follows a significant increase in OGTT uptake due to home testing.

April 10, 2024
3 Articles

Further Reading